Neural markers associated with working memory and emotional regulation are linked to future depression severity in young adults.

Identifying specific depressive symptom profiles in youth can highlight unique clinical and social-ecological determinants of health.

As health care costs increase, many companies plan to reduce benefits and health care coverage to avoid that additional expense.

Adults aged 40 years and older with symptoms of cognitive impairment may now qualify for a recently approved blood test for Alzheimer disease.

The American Academy of Neurology and American Headache Society offer updated recommendations on which medications may preventing migraine.

Low-carb diets offer greater cardiometabolic benefits beyond managing weight and obesity compared with other popular diets.

Effective pain management may help prevent suicidal ideation among US service members and veterans experiencing pain interference.

Students with ADHD, sensory disabilities, or learning disorders vs without disabilities are more likely to report high-risk substance use.

Plasma p-tau217 levels may not be a reliable biomarker for early cognitive impairment in patients with Parkinson disease without dementia.

Patients with glaucoma may face an increased risk of developing neurodegenerative and cognitive disorders over a 10-year period.

Periconception parental vitamin B12 and postconception maternal RBC folate are associated with lower prevalence of birth defects.

"Brain fog" linked to menopause may be relieved with an estrogen hormone treatment that combines estriol and progesterone.